5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats. (Q54232558)

26 May 2018

title

5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats. (English)

1 reference

26 May 2018

author

Gareth Sanger

series ordinal

3

1 reference

26 May 2018

author name string

Smith MI

series ordinal

1

1 reference

26 May 2018

Banner SE

series ordinal

2

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

26 May 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

26 May 2018

volume

271

1 reference

26 May 2018

issue

1

1 reference

26 May 2018

page(s)

61-64

1 reference

26 May 2018

Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

N-[(1-Butyl-4-piperidinyl)methyl]-3,4- dihydro-2H-[1,3]oxazino[3,2-a]indole- 10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

RS 39604: a potent, selective and orally active 5‐HT4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Modulation of ion channels by protein phosphorylation and dephosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

SB-207266: 5-HT4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

Selective and functional 5-hydroxytryptamine4 receptor antagonism by SB 207266

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900513-3

7 January 2021

10.1016/S0304-3940(99)00513-3

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

10471214

1 reference

26 May 2018